Pickard, RobertStarr, KathrynMacLennan, GraemeKilonzo, MaryLam, ThomasThomas, Ruth ElizabethBurr, JenniferNorrie, JohnMcPherson, GladysMcDonald, AlisonShearer, KirstyGillies, KatieAnson, KennethBoachie, CharlesN'Dow, JamesBurgess, NeilClark, TerryCameron, SarahMcClinton, Samuel2015-11-052015-11-052015-08-01Pickard, R, Starr, K, MacLennan, G, Kilonzo, M, Lam, T, Thomas, R E, Burr, J, Norrie, J, McPherson, G, McDonald, A, Shearer, K, Gillies, K, Anson, K, Boachie, C, N'Dow, J, Burgess, N, Clark, T, Cameron, S & McClinton, S 2015, 'Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults : a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)', Health Technology Assessment, vol. 19, no. 63, pp. 1-171. https://doi.org/10.3310/hta196301366-5278ORCID: /0000-0002-1039-5646/work/98038535ORCID: /0000-0001-7890-2854/work/136481761ORCID: /0000-0002-8316-2616/work/161798400ORCID: /0000-0001-5340-0081/work/162725507ORCID: /0000-0002-3450-4536/work/170010860http://hdl.handle.net/2164/5166Funding This project was funded by the National Institute for Health Research Health Technology Assessment programme This report The research reported in this issue of the journal was funded by the HTA programme as project number 08/71/01. The contractual start date was in June 2010. The draft report began editorial review in November 2014 and was accepted for publication in April 2015. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.17142082292engSDG 3 - Good Health and Well-beingupper urinary-tractsmooth-musclemedical therapyemergency-departmentinduced activationUnited-Statesin-vitrocalculimetaanalysisfacilitateR MedicineNational Institute for Health Research (NIHR)08/71/01RJournal article10.3310/hta196301963